- Report
- May 2024
- 129 Pages
Global
From €6179EUR$6,499USD£5,196GBP
- Report
- May 2024
- 132 Pages
Global
From €6179EUR$6,499USD£5,196GBP
- Report
- May 2024
- 139 Pages
Global
From €6179EUR$6,499USD£5,196GBP
- Report
- May 2024
- 140 Pages
Global
From €6179EUR$6,499USD£5,196GBP
- Report
- April 2023
- 115 Pages
Global
From €4516EUR$4,750USD£3,798GBP
- Report
- April 2023
- 120 Pages
Global
From €4516EUR$4,750USD£3,798GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €475EUR$500USD£400GBP
- Report
- November 2022
- 76 Pages
Global
From €1902EUR$2,000USD£1,599GBP
- Report
- June 2022
- 53 Pages
Global
From €1902EUR$2,000USD£1,599GBP
Nexium is a proton pump inhibitor (PPI) drug used to treat gastroesophageal reflux disease (GERD) and other gastrointestinal disorders. It is one of the most widely prescribed drugs in the world, and is available in both over-the-counter and prescription forms. Nexium works by reducing the amount of acid produced in the stomach, which helps to reduce symptoms of GERD and other gastrointestinal disorders. It is also used to treat ulcers, and can help to prevent them from recurring.
Nexium is part of a larger market of gastrointestinal drugs, which includes other PPIs, antacids, and H2 blockers. These drugs are used to treat a variety of gastrointestinal disorders, including GERD, ulcers, and heartburn. They are also used to prevent and treat complications of gastrointestinal disorders, such as bleeding and infection.
Some companies in the gastrointestinal drugs market include AstraZeneca, Pfizer, GlaxoSmithKline, Merck, and Takeda. Show Less Read more